The Affiliated Hospital of Qingdao University
Latest Information Update: 05 Jun 2023
At a glance
- Drugs Catequentinib (Primary) ; Toripalimab (Primary)
- Indications Gastric cancer; Oesophageal cancer
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 24 Nov 2022 New trial record
- 03 Nov 2022 Results assessing efficacy and safety of anlotinib-toripalimab combination therapy as a second-line treatment for advanced relapsed gastric or gastroesophageal junction carcinoma, published in the Oncologist